Round UUID: bccf9401-b2e9-4b1d-9b27-63d2cabccdfa
Prompt:
Predict treatment outcome using these comprehensive decision rules: 1. Histogen_Complex Specific Scoring System: Delta Complex: - Base Failure Risk Factors: a) If Treatment_Months > 90 AND TcQ_mass < 10000: +2 Failure Points b) If Genetic_Class_B_Matches > 2: +1 Failure Point c) If Treatment_Months < 60 AND TcQ_mass < 8000: +2 Failure Points - Mitigating Success Factors: a) If Genetic_Class_A_Matches > 1: -1 Failure Point b) If TcQ_mass > 20000: -2 Failure Points c) If Cohort is Delhi: -1 Failure Point Beta Complex: - Base Success Indicators: a) If TcQ_mass > 50000: +3 Success Points b) If Treatment_Months between 100-140: +2 Success Points c) If Genetic_Class_A_Matches > 1: +1 Success Point - Failure Risk Factors: a) If Treatment_Months > 150: +2 Failure Points b) If Genetic_Class_B_Matches > 2: +1 Failure Point c) If TcQ_mass < 15000: +1 Failure Point Omicron Complex: - Base Outcome Determination: a) If Treatment_Months > 120 AND TcQ_mass < 15000: +2 Failure Points b) If TcQ_mass > 30000: +2 Success Points c) If Genetic_Class_A_Matches > 1: +1 Success Point 2. Final Outcome Calculation: - Tally total Failure/Success Points - Apply Sex-based modifier: * Female: -0.5 Failure Points * Male: +0.5 Failure Points 3. Decision Threshold: - If Total Points > 2: Predict FAILURE - If Total Points < -2: Predict SUCCESS - If Points between -2 and 2: Requires further investigation 4. Confidence Modifiers: - High genetic match diversity increases prediction confidence - Cohort variations (Melbourne/Delhi/Lisbon) provide additional context - Extreme TcQ_mass values (very high or very low) warrant closer scrutiny Evaluation Process: 1. Identify Histogen_Complex 2. Calculate point-based risk assessment 3. Apply sex and cohort modifiers 4. Make final probabilistic prediction